 antibodi viru post-transfus hepat object preval antibodi viru anti-hcv relat seroconvers rate patient post-transfus non-a non-b hepat design retrospect analysi serum specimen set referral-bas univers hospit patient sixty-thre consecut patient non-a non-b post-transfus hepat open-heart surgeri patient follow-up serial serum test clinic evalu mean SD durat follow-up hepat onset month rang month seventeen patient acute-phas ill chronic diseas case main result patient transfus anti-hcv fifty-nin patient anti-hcv posit acute-phas hepat patient earli seroconvers day hepat onset late seroconvers day onset epidemiolog clinic biochem featur rate anti-hcv posit acute-phas ill differ patient chronic diseas month patient diseas antibodi activ progress diseas further long-term follow-up year patient diseas patient progress diseas anti-hcv neg conclus hepat viru major caus post-transfus hepat itali time anti-hcv seroconvers vari hepat onset acute-phas featur outcom diseas